With regard to the adoption and use of digital health solutions in clinical R&D, where are we as an industry? In our latest Pharma15 Live! debate, BBK Worldwide founding principal Bonnie A. Brescia posed this question to the panel of industry experts. Justin Johnson, CEO of Biotaware, answered in no uncertain terms: “[the industry] is five to eight years behind where it should be.” Do you agree?
If so, how are we going to ensure that, as an industry, we are utilizing digital health technologies to their full potential moving forward? Georgia Mitsi, PhD, MBA, Sr. Director of Search and Evaluation, Sunovion Pharmaceuticals, and Spyros Papapetropoulos, MD, PhD, Chief Medical Officer, Cavion Pharmaceuticals, shared their opinions on this heated topic as well.
Watch the full debate and join the conversation! What are your thoughts on the state of digital health? Is the healthcare industry doing enough to support the adoption of new technologies that enhance research efforts and the patient experience? Leave a comment below.